메뉴 건너뛰기




Volumn 10, Issue 12, 2003, Pages 1021-1034

The role of iron chelation in cancer therapy

Author keywords

Apoptosis; Cell cycle; Chemotherapy; Desferrioxamine; Drug design; Iron depletion; Ribonucleotide reductase

Indexed keywords

5 AMINO 4 METHYLISOQUINOLINE 1 CARBOXALDEHYDE THIOSEMICARBAZONE; 8 QUINOLINOL; AMIDINOHYDRAZONE; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CARBOPLATIN; CHELATING AGENT; COMPLEMENTARY RNA; CYCLOPHOSPHAMIDE; DAUNORUBICIN; DEFERASIROX; DEFEROXAMINE; DEFERRIFERRITHIOCIN; DOXORUBICIN; EDETIC ACID; ETOPOSIDE; FERRITIN; GALLIUM; IRON; IRON CHELATING AGENT; PHENIPRAZINE; PYRIDINE DERIVATIVE; PYRIDOXAL ISONICOTINOYLHYDRAZONE; RAZOXANE; SEMICARBAZONE DERIVATIVE; TACHPYRIDINE; THIOSEMICARBAZONE DERIVATIVE; THIOTEPA; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 0038324398     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929867033457638     Document Type: Review
Times cited : (210)

References (214)
  • 27
  • 69
    • 0037963242 scopus 로고
    • Critical Stability Constants: New York Plenum Press
    • Martell, A. E.; Smith, R. M. Critical Stability Constants: New York Plenum Press; 1977.
    • (1977)
    • Martell, A.E.1    Smith, R.M.2
  • 165
    • 0009498234 scopus 로고
    • Piperazine derivatives
    • U. K. Patent # 1,234,935
    • Creighton, A. M. Piperazine derivatives. U. K. Patent # 1,234,935, 1971.
    • (1971)
    • Creighton, A.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.